Ribonucleotide reductase immunoreactivity in adenocarcinoma cells and malignant or reactive mesothelial cells in serous effusions

Acta Cytologica

Volumn 47, Issue 2, 2003, Pages 209-215

  Okamura, Hiroshi ^a   Kamei, Toshiaki ^b   Sakuma, Nobuo ^a   Hanai, Nobuo ^c   Ishihara, Tokuhiro ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yamaguchi Prefectual Central Hospital   (Japan)

^c KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Adenocarcinoma; Cell proliferation; Immunocytochemistry; Mesothelioma; Mesothelium; Ribonucleotide reductases; Serous effusion

Indexed keywords

BIOTIN; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; RIBONUCLEOTIDE REDUCTASE; STREPTAVIDIN;

ADENOCARCINOMA; ARTICLE; CANCER CELL; CELL COUNT; CONTROLLED STUDY; CYTOPLASM; EFFUSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMEAR;

EID: 0344837318     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326506     Document Type: Article

References (27)

1. Bedrossian CWM: Diagnostic problems in serous effusions. Diagn Cytopathol 1998;19:131-137
2. Nance KV, Silverman JF: The utility of ancillary techniques in effusion cytology. Diagn Cytopathol 1992;8:185-189
3. Lozano MD, Panizo A, Toledo GR, Sola JJ, Pardo-Mindán J: Immunocytochemistry in the differential diagnosis of serous effusions: A comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 2001;93:68-72
4. Fetsch PA, Abati A: Immunocytochemistry in effusion cytology: A contemporary review. Cancer 2001;93:293-308
5. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715
6. Celis JE, Celis A: Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: Subdivision of S phase. Proc Natl Acad Sci USA 1985;82:3262-3266
7. Bravo R, Macdonald-Bravo H: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 1987;105:1549-1554
8. Pelosi G, Bresaola E, Manfrin E, Rodella S, Schiavon I, Iannucci A: Immunocytochemical detection of cell proliferation-related antigens in cytologic smears of human malignant neoplasms using PC10, reactive with proliferating cell nuclear antigen, and Ki-67: A comparative study. Arch Pathol Lab Med 1994;118:510-516
9. Saleh H, Bober P, Tabaczka P: Value of Ki67 immunostain in identification of malignancy in serous effusions. Diagn Cytopathol 1999;20:24-28
10. Sikora J, Dworacki G, Zeromski J: DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions. Lung 1996;174:303-313
11. EL-Habashi AH, Freeman SM, EL-Morsi B, EL-Didi M, Martin A, Marrogi AJ: DNA ploidy and proliferating cell nuclear antigen image analysis of peritoneal and pleural effusions: A possible diagnostic role. Acta Cytol 1997;41:636-648
12. Thelander L, Reichard P: Reduction of ribonucleotides. Ann Rev Biochem 1979;48:133-158
13. Thelander L, Erikisson S, Åkerman M: Ribonucleotide reductase from calf thymus: Separation of the enzyme into two nonidentical subunits, proteins M1 and M2. J Biol Chem 1980;255:7426-7432
14. Thelander M, Gräslund A, Thelander L: Subunit M2 of mammalian ribonucleotide reductase. J Biol Chem 1985;260:2737-2741
15. Eriksson S, Gräslund A, Skog S, Thelander L, Tribukait B: Cell cycle-dependent regulation of mammalian ribonucleotide reductase: The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J Biol Chem 1984;259:11695-11700
16. Engström Y, Eriksson S, Jildevik I, Skog S, Thelander L, Tribukait B: Cell cycle-dependent expression of mammalian ribonucleotide reductase: Differential regulation of the two subunits. J Biol Chem 1985;260:9114-9116
17. Engström Y, Rozell B: Immunocytochemical evidence for the cytoplasmic localization and differential expression during the cell cycle of the M1 and M2 subunits of mammalian ribonucleotide reductase. EMBO J 1988;7:1615-1620
18. Björklund S, Skog S, Tribukait B, Thelander L: S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry 1990;29:5452-5458
19. Mann GJ, Musgrove EA, Fox RM, Thelander L: Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation. Cancer Res 1988;48:5151-5156
20. Gordon HL, Bardos TJ, Ambrus JL: Comparative study of ribonucleotide reductase activities in normal and neoplastic human tissue. Res Commun Chem Pathol Pharmacol 1970;1:749-756
21. Saeki T, Takahashi T, Okabe M, Furuya A, Hanai N, Yamagami K, Mandai K, Moriwaki S, Doihara H, Takashima S, Salomon DS: Immunohistochemical detection of ribonucleotide reductase in human breast tumors. Int J Oncol 1995;6:523-529
22. Van der Kwast TH, Versnel MA, Delahaye M, de Jong A, Zondervan PE, Hoogsteden H: Expression of epithelial membrane antigen on malignant mesothelioma cells: An immunocytochemical and immunoelectron microscopic study. Acta Cytol 1988;32:169-174
23. Neubauer A, Thalmann U, Musch R, Großer H, Loddenkemper R, Huhn D: Prospective comparison of the diagnostic value of cytology and immunocytology in pleural effusions evaluated by means of thoracoscopy and pleural biopsies. Klin Wochenschr 1987;65:400-406 (in German with English abstr)
24. Mullick SS, Green LK, Ramzy I, Brown RW, Smith D, Gondo MM, Cagle PT: p53 Gene product in pleural effusions: Practical use in distinguishing benign from malignant cells. Acta Cytol 1996;40:855-860
25. Roberts F, Harper CM, Downie I, Burnett RA: Immunohisto-chemical analysis still has a limited role in the diagnosis of malignant mesothelioma: A study of thirteen antibodies. Am J Clin Pathol 2001;116:253-262
26. Ramael M, Jacobs W, Weyler J, Van Meerbeeck J, Bialasiewicz P, Van den Bossche J, Buysse C, Vermeire P, Van Marck E: Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA). J Pathol 1994;172:247-253
27. Bethwaite PB, Delahunt B, Holloway LJ, Thornton A: Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma. Pathology 1995;27:1-4